Melar Acquisition Corp. I (MACI) is a special purpose acquisition company (SPAC) strategically focused on merging with high-growth entities within the technology and healthcare sectors. Backed by a seasoned management team, MACI seeks to leverage its industry expertise to identify and invest in innovative companies that are well-positioned in rapidly evolving markets. With a commitment to creating long-term value and promoting innovation, MACI offers institutional investors a unique opportunity to engage in transformative industries that are poised for substantial growth and advancement.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -0.75% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.36 |
| Price-to-Book | 1.42 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 44.03 |
| Quarterly Earnings Growth (YoY) | -50.70% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $21.62M |
| Float | $13.03M |
| % Insiders | 0.00% |
| % Institutions | 418.29% |
Volatility is currently expanding